Prestige Biologics hires former Lonza official as new director
Date
2024-05-23
Prestige Biologics, a biopharmaceutical contract development, engineering, and manufacturing organization (CDEMO), said it has appointed Fionn Huang, formerly of the global CDMO Lonza Group, as the new director for its international business development.
